Evidence map›Paper›PMID 18351317›Full record

ReviewDer Urologe. Ausg. A2008

[Laser-based resecting techniques in the treatment of benign prostatic obstruction].

A J Gross, T Bach

Abstract readComparative StudyEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A J GrossAbteilung für Urologie, Asklepios Klinik Barmbek, Rübenkamp 220, 22291 Hamburg, Deutschland. an.gross@asklepios.com
T Bach

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A brought variety of options are at hand in the treatment of benign prostatic obstruction. During the last decades multiple therapeutic approaches have been pushed on the market to compete with the known Gold-Standard, the monopolar TUR-P. Only few have stood the test of time. The first wave of laser-based prostate surgery took place, when the Nd:YAG laser was introduced into clinical urology. However, operating time was long, surgical outcome often poor and the risk of serious complications was high. This lead to the vanishing of Nd:YAG lasers in clinical routine. During the last years, with growing experience in laser physics and the development of new laser types, the laser-based prostatic surgery gained importance. In clinical routine different vaporizing or resecting techniques are established and compete on the market. Aim of this article is to review those lasers, which are currently used in resection techniques and to highlight advantages, but also disadvantages of the different systems.

Indexed as

Equipment DesignHumansLasers, Solid-StateLaser TherapyMaleProstatic HyperplasiaTransurethral Resection of ProstateUrinary Bladder Neck Obstruction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.